{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:36:05Z","timestamp":1792791365204,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE027980"],"award-info":[{"award-number":["R01DE027980"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R56DE033249"],"award-info":[{"award-number":["R56DE033249"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["National Eye Institute"],"award-info":[{"award-number":["National Eye Institute"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY033622"],"award-info":[{"award-number":["R01EY033622"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08657-2","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:45:58Z","timestamp":1785311158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["IL-17 Receptor inhibition with brodalumab limits experimental periodontitis"],"prefix":"10.1186","volume":"24","author":[{"given":"Araceli","family":"Valverde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raza Ali","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Tokarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer","family":"Ceredon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Elshourbagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Nares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar R.","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"8657_CR1","doi-asserted-by":"publisher","first-page":"17038","DOI":"10.1038\/nrdp.2017.38","volume":"22","author":"DF Kinane","year":"2017","unstructured":"Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Reviews Disease Primers. 2017;22:17038.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"8657_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/prd.12331","volume":"84","author":"G Hajishengallis","year":"2020","unstructured":"Hajishengallis G, Chavakis T, Lambris JD. Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontol 2000. 2020;84(1):14\u201334.","journal-title":"Periodontol 2000"},{"key":"8657_CR3","doi-asserted-by":"crossref","unstructured":"Moutsopoulos NM, Konkel JE. 2018. Tissue-specific immunity at the oral mucosal barrier. Trends Immunol. 2018;39(4): 276\u2013287.","DOI":"10.1016\/j.it.2017.08.005"},{"issue":"1","key":"8657_CR4","doi-asserted-by":"publisher","first-page":"9796","DOI":"10.1038\/s41598-021-89002-z","volume":"7","author":"W Johnston","year":"2021","unstructured":"Johnston W, Rosier BT, Artacho A, Paterson M, Piela K, Delaney C, et al. Mechanical biofilm disruption causes microbial and immunological shifts in periodontitis patients. Sci Rep. 2021;7(1):9796.","journal-title":"Sci Rep"},{"key":"8657_CR5","doi-asserted-by":"crossref","unstructured":"Ardila CM, Vivares-Builes AM. Clinical efficacy of treatment of endodontic-periodontal lesions: a systematic scoping review of experimental studies. Int J Environ Res Public Health. 2022;19(20):13649.","DOI":"10.3390\/ijerph192013649"},{"issue":"6","key":"8657_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/idj.12630","volume":"71","author":"T Kwon","year":"2021","unstructured":"Kwon T, Lamster IB, Levin L. Current Concepts in the Management of Periodontitis. Int Dent J. 2021;71(6):462\u201376.","journal-title":"Int Dent J"},{"issue":"10","key":"8657_CR7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.it.2021.08.001","volume":"42","author":"G Hajishengallis","year":"2021","unstructured":"Hajishengallis G, Hasturk H, Lambris JD. C3-targeted therapy in periodontal disease: moving closer to the clinic. Trends Immunol. 2021;42(10):856\u201364.","journal-title":"Trends Immunol"},{"issue":"3","key":"8657_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s40120-024-00616-7","volume":"13","author":"H Bartak","year":"2024","unstructured":"Bartak H, Fareh T, Ben Othman N, Viard D, Cohen M, et al. Dental Adverse Effects of Anti-CD20 Therapies. Neurol Therapy. 2024;13(3):917\u201330.","journal-title":"Neurol Therapy"},{"key":"8657_CR9","doi-asserted-by":"publisher","first-page":"1160148","DOI":"10.3389\/fimmu.2023.1160148","volume":"14","author":"M Nolde","year":"2023","unstructured":"Nolde M, Alayash Z, Reckelkamm SL, Kocher T, Ehmke B, Holtfreter B, et al. Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study. Front Immunol. 2023;14:1160148.","journal-title":"Front Immunol"},{"key":"8657_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mam.2017.04.006","volume":"58","author":"TE Van Dyke","year":"2017","unstructured":"Van Dyke TE. Pro-resolving mediators in the regulation of periodontal disease. Mol Aspects Med. 2017;58:21\u201336.","journal-title":"Mol Aspects Med"},{"key":"8657_CR11","doi-asserted-by":"publisher","first-page":"1493818","DOI":"10.3389\/fcimb.2024.1493818","volume":"14","author":"N L\u00f3pez-Valverde","year":"2024","unstructured":"L\u00f3pez-Valverde N, Quispe-L\u00f3pez N, Blanco Rueda JA. Inflammation and immune response in the development of periodontal disease: a narrative review. Front Cell Infect Microbiol. 2024;14:1493818.","journal-title":"Front Cell Infect Microbiol"},{"key":"8657_CR12","doi-asserted-by":"publisher","first-page":"1385436","DOI":"10.3389\/fimmu.2024.1385436","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, Liu Y, Afzali H, Graves DT. An Update on Periodontal Inflammation and Bone Loss. Front Immunol. 2024;15:1385436.","journal-title":"Front Immunol"},{"issue":"2","key":"8657_CR13","doi-asserted-by":"publisher","first-page":"e12973","DOI":"10.1111\/cpr.12973","volume":"54","author":"Y Chen","year":"2021","unstructured":"Chen Y, Yang Q, Lv C, Chen Y, Zhao W, Li W, et al. NLRP3 regulates alveolar bone loss in ligature-induced periodontitis by promoting osteoclastic differentiation. Cell Prolif. 2021;54(2):e12973.","journal-title":"Cell Prolif"},{"issue":"1","key":"8657_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1902\/jop.2004.75.1.162","volume":"75","author":"V Lima","year":"2004","unstructured":"Lima V, Vidal FDP, Rocha FAC, Brito GAC, et al. Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. J Periodontol. 2004;75(1):162\u20138.","journal-title":"J Periodontol"},{"key":"8657_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9:556\u201367.","journal-title":"Nat Rev Immunol"},{"key":"8657_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","volume":"38","author":"N Amatya","year":"2017","unstructured":"Amatya N, Garg AV, Gaffen SL. IL-17 signaling: the yin and the yang. Trends Immunol. 2017;38:310\u201322.","journal-title":"Trends Immunol"},{"issue":"1","key":"8657_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/prd.12083","volume":"69","author":"C Zenobia","year":"2015","unstructured":"Zenobia C, Hajishengallis G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000. 2015;69(1):142\u201359.","journal-title":"Periodontol 2000"},{"key":"8657_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/0022034509339889","volume":"88","author":"H Ohyama","year":"2009","unstructured":"Ohyama H, Kato-Kogoe N, Kuhara A, Nishimura F, Nakasho K, Yamanegi K, et al. The involvement of il-23 and the th17 pathway in periodontitis. J Dent Res. 2009;88:633\u20138.","journal-title":"J Dent Res"},{"key":"8657_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1600-051X.2011.01752.x","volume":"38","author":"JP Allam","year":"2011","unstructured":"Allam JP, Duan Y, Heinemann F, Winter J, G\u00f6tz W, Deschner J, et al. Il-23-producing CD68 + Macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions. J Clin Periodontol. 2011;38:879\u201386.","journal-title":"J Clin Periodontol"},{"key":"8657_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/0022034512446341","volume":"91","author":"T Okui","year":"2012","unstructured":"Okui T, Aoki Y, Ito H, Honda T, Yamazaki K. The presence of il-17+\/foxp3 + Double-positive cells in periodontitis. J Dent Res. 2012;91:574\u20139.","journal-title":"J Dent Res"},{"issue":"9","key":"8657_CR21","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1021\/acs.jproteome.8b00263","volume":"17","author":"N Bostanci","year":"2018","unstructured":"Bostanci N, Bao K, Li X, Maekawa T, Grossmann J, Panse C, et al. Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis. J Proteome Res. 2018;17(9):3153\u201375.","journal-title":"J Proteome Res"},{"key":"8657_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discovery. 2012;11:763\u201376.","journal-title":"Nat Rev Drug Discovery"},{"key":"8657_CR23","doi-asserted-by":"publisher","first-page":"229ra240","DOI":"10.1126\/scitranslmed.3007696","volume":"6","author":"NM Moutsopoulos","year":"2014","unstructured":"Moutsopoulos NM, Konkel J, Sarmadi M, Eskan MA, Wild T, Dutzan N, et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17\u2013driven inflammatory bone loss. Sci Transl Med. 2014;6:229ra240.","journal-title":"Sci Transl Med"},{"issue":"3","key":"8657_CR24","doi-asserted-by":"publisher","first-page":"e0265486","DOI":"10.1371\/journal.pone.0265486","volume":"17","author":"A Wilharm","year":"2022","unstructured":"Wilharm A, Binz C, Sandrock I, Rampoldi F, Lienenklaus S, Blank E, et al. Interleukin-17 is disease promoting in early stages and protective in late stages of experimental periodontitis. PLoS ONE. 2022;17(3):e0265486.","journal-title":"PLoS ONE"},{"issue":"6","key":"8657_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","volume":"43","author":"DD Patel","year":"2015","unstructured":"Patel DD, Kuchroo VK. Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions. Immunity. 2015;43(6):1040\u201351.","journal-title":"Immunity"},{"issue":"10","key":"8657_CR26","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.4049\/jimmunol.2001432","volume":"206","author":"CMF Pacheco","year":"2021","unstructured":"Pacheco CMF, Maltos KLM, Shehabeldin MS, Thomas LL, Zhuang Z, Yoshizawa S, Verdelis K, Gaffen SL, Garlet GP, Little SR, Sfeir C. Local Sustained Delivery of Anti-IL-17A Antibodies Limits Inflammatory Bone Loss in Murine Experimental Periodontitis. J Immunol. 2021;206(10):2386\u201392.","journal-title":"J Immunol"},{"key":"8657_CR27","doi-asserted-by":"publisher","first-page":"105555","DOI":"10.1016\/j.archoralbio.2022.105555","volume":"144","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang AX, Wu Y, Zhang S. IL-1 receptor antagonist (IL-1RA) suppresses a hyper-IL-17 response-mediated bone loss in a murine experimental periodontitis. Arch Oral Biol. 2022;144:105555.","journal-title":"Arch Oral Biol"},{"issue":"9","key":"8657_CR28","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","volume":"78","author":"DG McGonagle","year":"2019","unstructured":"McGonagle DG, McInnes IB, Kirkham BW, Sherlock J, Moots R. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. Ann Rheum Dis. 2019;78(9):1167\u201378.","journal-title":"Ann Rheum Dis"},{"key":"8657_CR29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41586-022-05116-y","volume":"609","author":"SC Wilson","year":"2022","unstructured":"Wilson SC, Caveney NA, Yen M, et al. Organizing structural principles of the IL-17 ligand\u2013receptor axis. Nature. 2022;609:622\u20139.","journal-title":"Nature"},{"issue":"1","key":"8657_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.71.1.1","volume":"71","author":"S Aggarwal","year":"2002","unstructured":"Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71(1):1\u20138.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"8657_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","volume":"38","author":"N Amatya","year":"2017","unstructured":"Amatya N, Garg AV, Gaffen SL. IL-17 Signaling: The Yin and the Yang. Trends Immunol. 2017;38(5):310\u201322.","journal-title":"Trends Immunol"},{"key":"8657_CR32","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","volume":"181","author":"JF Wright","year":"2008","unstructured":"Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP, Whitters MJ, et al. The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex. J Immunol. 2008;181:2799\u2013805.","journal-title":"J Immunol"},{"key":"8657_CR33","doi-asserted-by":"publisher","first-page":"13447","DOI":"10.1074\/jbc.M700499200","volume":"282","author":"JF Wright","year":"2007","unstructured":"Wright JF, Guo Y, Quazi A, Luxenberg DP, Bennett F, Ross JF, et al. Identification of an interleukin 17F\/17A heterodimer in activated human CD4 + T cells. J Biol Chem. 2007;282:13447\u201355.","journal-title":"J Biol Chem"},{"key":"8657_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585\u2013600.","journal-title":"Nat Rev Immunol"},{"key":"8657_CR35","doi-asserted-by":"publisher","first-page":"eaau9657","DOI":"10.1126\/sciimmunol.aau9657","volume":"4","author":"Y Su","year":"2019","unstructured":"Su Y, Huang J, Zhao X, Lu H, Wang W, Yang XO. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation. Sci Immunol. 2019;4:eaau9657.","journal-title":"Sci Immunol"},{"issue":"3","key":"8657_CR36","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cyto.2013.09.012","volume":"64","author":"M Sohda","year":"2013","unstructured":"Sohda M, Misumi Y, Tashiro K, Yamazaki M, Saku T, Oda K. Identification of a soluble isoform of human IL-17RA generated by alternative splicing. Cytokine. 2013;64(3):642\u20135.","journal-title":"Cytokine"},{"key":"8657_CR37","unstructured":"Fala L. Brodalumab: a new IL-17RA antagonist approved for moderate-to-severe plaque psoriasis. Am Health Drug Benefits. Available from: https:\/\/www.ahdbonline.com\/issues\/2018\/april-2018-vol-11-ninth-annual-payers-guide\/brodalumab-brodalumab-a-new-il-17ra-antagonist-approved-for-moderate-to-severe-plaque-psoriasis. Accessed 30 Jan 2025."},{"key":"8657_CR38","first-page":"415","volume":"19","author":"N Babaei","year":"2025","unstructured":"Babaei N, Gill M, Cervantes M, Kim D, Yang S, Wu JJ. Brodalumab for Moderate-to-Severe Psoriasis: A Comprehensive Review of Efficacy, Safety, and Clinical Positioning. Biologics. 2025;19:415\u201322.","journal-title":"Biologics"},{"key":"8657_CR39","doi-asserted-by":"crossref","unstructured":"Uttamani JR, Naqvi AR, Estepa AMV, Kulkarni V, Brambila MF, Mart\u00ednez G, et al. Downregulation of miRNA-26 in chronic periodontitis interferes with innate immune responses and cell migration by targeting phospholipase C beta 1. J Clin Periodontol. 2023; 50:102\u2010113.","DOI":"10.1111\/jcpe.13715"},{"issue":"10","key":"8657_CR40","doi-asserted-by":"publisher","first-page":"e70044","DOI":"10.1002\/iid3.70044","volume":"12","author":"JR Uttamani","year":"2024","unstructured":"Uttamani JR, Kulkarni V, Valverde A, Naqvi RA, Van Dyke T, Nares S, Naqvi AR. Dynamic changes in macrophage polarization during the resolution phase of periodontal disease. Immun Inflamm Dis. 2024;12(10):e70044.","journal-title":"Immun Inflamm Dis"},{"key":"8657_CR41","doi-asserted-by":"publisher","first-page":"1214810","DOI":"10.3389\/fimmu.2023.1214810","volume":"14","author":"I Ahmad","year":"2023","unstructured":"Ahmad I, Naqvi RA, Valverde A, Naqvi AR. LncRNA MALAT1\/microRNA-30b axis regulates macrophage polarization and function. Front Immunol. 2023;14:1214810.","journal-title":"Front Immunol"},{"issue":"3","key":"8657_CR42","doi-asserted-by":"publisher","first-page":"e10474","DOI":"10.1002\/jbm4.10474","volume":"5","author":"MB Chavez","year":"2021","unstructured":"Chavez MB, Chu EY, Kram V, et al. Guidelines for Micro\u2013Computed Tomography Analysis of Rodent Dentoalveolar Tissues. JBMR Plus. 2021;5(3):e10474.","journal-title":"JBMR Plus"},{"key":"8657_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-immunol-101819-092536","volume":"39","author":"S Majumder","year":"2021","unstructured":"Majumder S, McGeachy MJ. IL-17 in the Pathogenesis of Disease: Good Intentions Gone Awry. Annu Rev Immunol. 2021;39:537\u201356.","journal-title":"Annu Rev Immunol"},{"key":"8657_CR44","doi-asserted-by":"publisher","first-page":"1656422","DOI":"10.3389\/fimmu.2025.1656422","volume":"16","author":"I Xu Lou","year":"2025","unstructured":"Xu Lou I, Zhou H, Wan H. The critical role of Th17 cells and IL-17A in autoimmune and inflammation-associated neurological diseases: mechanisms and therapeutic perspectives. Front Immunol. 2025;16:1656422.","journal-title":"Front Immunol"},{"issue":"5","key":"8657_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/0022034510397838","volume":"90","author":"R Kobayashi","year":"2011","unstructured":"Kobayashi R, Kono T, Bolerjack BA, Fukuyama Y, Gilbert RS, Fujihashi K, Ruby J, et al. Induction of IL-10-producing CD4 + T-cells in chronic periodontitis. J Dent Res. 2011;90(5):653\u20138.","journal-title":"J Dent Res"},{"key":"8657_CR46","doi-asserted-by":"publisher","first-page":"709438","DOI":"10.3389\/fphys.2021.709438","volume":"12","author":"M Mart\u00ednez-Garc\u00eda","year":"2021","unstructured":"Mart\u00ednez-Garc\u00eda M, Hern\u00e1ndez-Lemus E. Periodontal inflammation and systemic diseases: an overview. Front Physiol. 2021;12:709438.","journal-title":"Front Physiol"},{"issue":"7","key":"8657_CR47","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.4049\/jimmunol.1600859","volume":"197","author":"CT Lee","year":"2016","unstructured":"Lee CT, Teles R, Kantarci A, Chen T, McCafferty J, Starr JR, et al. Resolvin E1 Reverses Experimental Periodontitis and Dysbiosis. J Immunol. 2016;197(7):2796\u2013806.","journal-title":"J Immunol"},{"issue":"1","key":"8657_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s11658-025-00756-0","volume":"30","author":"F Reisch","year":"2025","unstructured":"Reisch F, Sch\u00e4fer M, Labuz D, Machelska H, Stehling S, P\u00fcschel GP, et al. Functional humanization of 15-lipoxygenase-1 (Alox15) protects mice from dextran sodium sulfate induced intestinal inflammation. Cell Mol Biology Lett. 2025;30(1):81.","journal-title":"Cell Mol Biology Lett"},{"key":"8657_CR49","doi-asserted-by":"publisher","first-page":"1042420","DOI":"10.3389\/fphar.2022.1042420","volume":"13","author":"Y Benatzy","year":"2022","unstructured":"Benatzy Y, Palmer MA, Br\u00fcne B. Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology. Front Pharmacol. 2022;13:1042420.","journal-title":"Front Pharmacol"},{"issue":"1","key":"8657_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-025-00478-1","volume":"14","author":"RS de Molon","year":"2026","unstructured":"de Molon RS, Vernal R, Oliveira GE, Steffens JP, Ervolino E, Theodoro LH, et al. Inflammatory bone loss and signaling pathways in periodontitis: mechanistic insights and emerging therapeutic strategies. Bone Res. 2026;14(1):1.","journal-title":"Bone Res"},{"key":"8657_CR51","doi-asserted-by":"publisher","first-page":"1578635","DOI":"10.3389\/fimmu.2025.1578635","volume":"16","author":"Z Tang","year":"2025","unstructured":"Tang Z, Jin L, Yang Y. The Dual Role of IL-17 in Periodontitis Regulating Immunity and Bone Homeostasis. Front Immunol. 2025;16:1578635.","journal-title":"Front Immunol"},{"key":"8657_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/154405910708600409","volume":"86","author":"A Beklen","year":"2007","unstructured":"Beklen A, Ainola M, Hukkanen M, G\u00fcrgan C, Sorsa T, Konttinen YT. Mmps, il-1, and tnf are regulated by il-17 in periodontitis. J Dent Res. 2007;86:347\u201351.","journal-title":"J Dent Res"},{"key":"8657_CR53","doi-asserted-by":"publisher","first-page":"742925","DOI":"10.3389\/fimmu.2021.742925","volume":"12","author":"N Huang","year":"2021","unstructured":"Huang N, Dong H, Luo Y, Shao B. Th17 Cells in Periodontitis and Its Regulation by A20. Front Immunol. 2021;12:742925.","journal-title":"Front Immunol"},{"issue":"1","key":"8657_CR54","doi-asserted-by":"publisher","first-page":"e20191123","DOI":"10.1084\/jem.20191123","volume":"217","author":"P Zwicky","year":"2020","unstructured":"Zwicky P, Unger S, Becher B. Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective. J Exp Med. 2020;217(1):e20191123.","journal-title":"J Exp Med"},{"issue":"1","key":"8657_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12903-024-04077-0","volume":"24","author":"MA Alarc\u00f3n-S\u00e1nchez","year":"2024","unstructured":"Alarc\u00f3n-S\u00e1nchez MA, Guerrero-Vel\u00e1zquez C, Becerra-Ruiz JS, Rodr\u00edguez-Monta\u00f1o R, Avetisyan A, Heboyan A. IL-23\/IL-17 axis levels in gingival crevicular fluid of subjects with periodontal disease: a systematic review. BMC Oral Health. 2024;24(1):302.","journal-title":"BMC Oral Health"},{"key":"8657_CR56","doi-asserted-by":"publisher","first-page":"7464","DOI":"10.1038\/ncomms8464","volume":"6","author":"A Akitsu","year":"2015","unstructured":"Akitsu A, Ishigame H, Kakuta S, Chung SH, Ikeda S, Shimizu K, et al. IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2(+)V\u03b36(+)\u03b3\u03b4 T cells. Nat Commun. 2015;6:7464.","journal-title":"Nat Commun"},{"key":"8657_CR57","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3389\/fimmu.2018.01611","volume":"9","author":"MJ Park","year":"2018","unstructured":"Park MJ, Moon SJ, Lee EJ, Jung KA, Kim EK, Kim DS, et al. IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis. Front Immunol. 2018;9:1611.","journal-title":"Front Immunol"},{"key":"8657_CR58","doi-asserted-by":"publisher","first-page":"105555","DOI":"10.1016\/j.archoralbio.2022.105555","volume":"144","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang AX, Wu Y, Zhang S. IL-1 receptor antagonist (IL-1RA) suppresses a hyper-IL-17 response-mediated bone loss in a murine experimental periodontitis. Arch Oral Biol. 2022;144:105555.","journal-title":"Arch Oral Biol"},{"key":"8657_CR59","unstructured":"Taskin C, Aydinyurt HS, Sancak T, Gevrek F, Demir C. Effects of IL-17 inhibition with secukinumab in experimental periodontitis. Research Square. Available from: https:\/\/assets-eu.researchsquare.com\/files\/rs-3326763\/v1\/78207912-4d34-426e-a295-87ad6786ae5a.pdfc1699798047 26 Sept 2023."},{"issue":"8","key":"8657_CR60","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.4049\/jimmunol.1900532","volume":"204","author":"L Sun","year":"2020","unstructured":"Sun L, Girnary M, Wang L, Jiao Y, Zeng E, Mercer K, Zhang J, Marchesan JT, Yu N, Moss K, Lei YL, Offenbacher S, Zhang S. IL-10 Dampens an IL-17-Mediated Periodontitis-Associated Inflammatory Network. J Immunol. 2020;204(8):2177\u201391.","journal-title":"J Immunol"},{"key":"8657_CR61","doi-asserted-by":"publisher","first-page":"108881","DOI":"10.1016\/j.intimp.2022.108881","volume":"108","author":"S Ni","year":"2022","unstructured":"Ni S, Shan F, Geng J. Interleukin-10 family members: Biology and role in the bone and joint diseases. Int Immunopharmacol. 2022;108:108881.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"8657_CR62","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/ar3379","volume":"13","author":"B Zhao","year":"2011","unstructured":"Zhao B, Ivashkiv LB. Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors. Arthritis Res Therapy. 2011;13(4):234.","journal-title":"Arthritis Res Therapy"},{"issue":"5","key":"8657_CR63","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349\u201361.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8657_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/THC-220092","volume":"31","author":"W Zhang","year":"2023","unstructured":"Zhang W, Guan N, Zhang X, Liu Y, Gao X, Wang L. Study on the imbalance of M1\/M2 macrophage polarization in severe chronic periodontitis. Technol Health Care. 2023;31(1):117\u201324.","journal-title":"Technol Health Care"},{"key":"8657_CR65","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jdsr.2022.10.002","volume":"58","author":"L Yin","year":"2022","unstructured":"Yin L, Li X, Hou J. Macrophages in periodontitis: A dynamic shift between tissue destruction and repair. Japanese Dent Sci Rev. 2022;58:336\u201347.","journal-title":"Japanese Dent Sci Rev"},{"key":"8657_CR66","doi-asserted-by":"crossref","unstructured":"Ye B, Tao T, Zhao A, Wen L, He X, Liu Y, Fu Q, Mi W, Lou J. Blockade of IL-17A\/IL-17R Pathway Protected mice from sepsis-associated encephalopathy by inhibition of microglia activation. Mediators Inflamm. 2019:8461725.","DOI":"10.1155\/2019\/8461725"},{"issue":"2","key":"8657_CR67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/0022034517736030","volume":"97","author":"JE Konkel","year":"2018","unstructured":"Konkel JE, Moutsopoulos NM. Unique Tailoring of Th17 at the Gingival Oral Mucosal Barrier. J Dent Res. 2018;97(2):128\u201331.","journal-title":"J Dent Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08657-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08657-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08657-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:02:10Z","timestamp":1786377730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08657-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8657"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08657-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed in accordance with institutional guidelines for the care and use of laboratory animals and complied with applicable national regulations. All procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of University of Illinois Chicago (protocol number 25\u2013079). Animals were monitored regularly to minimize pain and distress, and all efforts were made to reduce animal numbers and suffering.","order":1,"name":"Ethics","label":"Animal studies","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to enrollment, and all samples\/data were de-identified prior to analysis to protect participant confidentiality.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1024"}}